SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

Updated IRB Policy and Guidance

September 14, 2022 - SCI Communications

The Stanford HRPP Policy Manual (Chapters 3.9, 3.10 and 3.11) and Stanford Prompt Reporting Guidance (GUI-P13) have been updated effective July 2022.  

Substantial changes include: 

·        Updated definition of an Unanticipated Problem (UP) to (underlined text is new): 

o   Unexpected, and

o   Related or Possibly Related and

o   Places Subjects or Others at a Greater Risk of Harm (notably, this includes privacy-related risks)

·        Expanded definitions for: 

o   Noncompliance

o   Serious Noncompliance

o   Continuing Noncompliance

References:

  • Updated Stanford HRPP Policy Manual Chapters 3.9, 3.10, 3.11 at https://researchcompliance.stanford.edu/panels/hs/policies
  • Update Stanford Prompt Reporting Guidance (GUI-P13) at https://researchcompliance.stanford.edu/panels/hs/policies/guidances

Action: Please review the updated definition of a UP in the attached guidance or at the link below as this is substantially different from the prior definition. Please also review the updated definitions that will apply to various types of noncompliance. 

Additional training and communications will occur in various venues.

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube